HIV prevention among injection drug users: The need for integrated models

被引:0
|
作者
David S. Metzger
Helen Navaline
机构
[1] HIV Prevention Research Division,University of Pennsylvania Center for Studies of Addiction
关键词
HIV infection; Injection drug users; AIDS; Prevention;
D O I
10.1093/jurban/jtg083
中图分类号
学科分类号
摘要
Opportunistic infections (OIs) were first recognized among injection drug users (IDUs) in New York City in 1981. By the mid-1980s, OIs had become associated with HIV infection, and attention began to focus on efforts to prevent HIV transmission among IDUs. Since then, a range of prevention strategies has been implemented and evaluated in an attempt to reduce the spread of HIV infection among drug users. These prevention strategies include (1) HIV testing and counseling and educational and behavioural interventions delivered through community outreach; (2) condom, bleach, and needle distribution and syringe access and exchange programs: (3) substance abuse treatment; and, more recently, (4) prevention interventions targeting HIV-positive IDUs. Data from evaluations of these strategies over the past 20 years have provided substantial evidence of effectiveness and have helped to inform network-based and structural interventions. Despite the cumulative empirical evidence, however, research findings have yet to be widely, disseminated, adopted, and implemented in a sustained and integrated fashion. The reasons for this are unclear, but point to a need for improved communications with program developers and community planners to facilitate the implementation and evaluation of integrated intervention strategies, and for collaborative research to help understand policy, legal, economic, and local barriers to implementation.
引用
收藏
页码:iii59 / iii66
相关论文
共 50 条
  • [11] Prevention of HIV Infection among Injection Drug Users in Resource-Limited Settings
    Vlahov, David
    Robertson, Angela M.
    Strathdee, Steffanie A.
    CLINICAL INFECTIOUS DISEASES, 2010, 50 : S114 - S121
  • [12] DEREGULATION OF THE SALE AND POSSESSION OF SYRINGES FOR HIV PREVENTION AMONG INJECTION-DRUG USERS
    VLAHOV, D
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1995, 10 (01): : 71 - 72
  • [13] Agents of Change: Peer Mentorship as HIV Prevention Among HIV-Positive Injection Drug Users
    Mackenzie, Sonja
    Pearson, Charles
    Frye, Victoria
    Gomez, Cynthia A.
    Latka, Mary H.
    Purcell, David W.
    Knowlton, Amy R.
    Metsch, Lisa R.
    Tobin, Karin E.
    Valverde, Eduardo E.
    Knight, Kelly R.
    SUBSTANCE USE & MISUSE, 2012, 47 (05) : 522 - 534
  • [14] Social support among HIV positive injection drug users: Implications to integrated intervention for HIV positives
    Knowlton, A
    Hua, W
    Latkin, C
    AIDS AND BEHAVIOR, 2004, 8 (04) : 357 - 363
  • [15] Social Support Among HIV Positive Injection Drug Users: Implications to Integrated Intervention for HIV Positives
    Amy Knowlton
    Wei Hua
    Carl Latkin
    AIDS and Behavior, 2004, 8 : 357 - 363
  • [16] Prevalence of HIV among injection drug users in Georgia
    Chikovani, Ivdity
    Goguadze, Ketevan
    Ranade, Sudit
    Wertlieb, Mollie
    Rukhadze, Natia
    Gotsadze, George
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2011, 14
  • [17] HIV STIGMA AND RISK AMONG INJECTION DRUG USERS
    Earnshaw, Valerie
    Smith, Laramie R.
    Chaudoir, Stephenie R.
    Copenhaver, Michael M.
    ANNALS OF BEHAVIORAL MEDICINE, 2012, 43 : S60 - S60
  • [18] HIV incidence among injection drug users in Vancouver
    Remis, RS
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2002, 166 (07) : 908 - 909
  • [19] 100% HIV Prevention: Missed Opportunities for Injection Drug Users?
    Bradley-Springer, Lucy
    JANAC-JOURNAL OF THE ASSOCIATION OF NURSES IN AIDS CARE, 2015, 26 (05): : 503 - 505
  • [20] Prevention of HIV transmission among intravenous drug users
    Benyamina, Amine
    Blecha, Lisa
    Lebeau, Bertrand
    Reynaud, Michel
    LANCET, 2010, 375 (9728): : 1782 - 1782